Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing RhoA / ROCK1 signaling
Environmental Toxicology · 2024
DOI: 10.1002/tox.23882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Yuhao Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Glioma, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Glioma, a type of malignant brain tumor, has become a challenging health issue globally in recent years.
Methods
In this study, we investigated the potential therapeutic role of scoparone in glioma and the underlying mechanism. Initially, transcriptome sequencing was conducted to identify genes that exhibited differential expression in glioma cells treated with scoparone compared to untreated cells. Subsequently, the impact of scoparone on the proliferation, migration, and invasion of glioma cells was assessed in vitro using a range of assays including cell viability, colony formation, wound healing, and transwell assays. Moreover, the apoptotic effects of scoparone on glioma cells were evaluated through flow cytometry and western blot analysis. Furthermore, we established a glioma xenograft mouse model to assess the in vivo antitumor activity of scoparone. Lastly, by integrating transcriptome analysis, we endeavored to unravel the molecular mechanisms underlying the observed antitumor effects of scoparone by examining the expression levels of RhoA/ROCK1 signaling pathway components using western blot analysis and qRT‐PCR.
Results
Our transcriptome sequencing results revealed that scoparone significantly downregulated RhoA/ROCK1 signaling in glioma cells. Furthermore, scoparone treatment inhibited glioma cell proliferation, migration, and invasion, and promoted cell apoptosis in vitro. Moreover, scoparone reduced tumor growth and prolonged survival in a glioma xenograft mouse model, and improved the toxicity of temozolomide. Finally, our results showed that the antitumor effects of scoparone were mediated by the suppression of RhoA/ROCK1 signaling.
Conclusion
Scoparone could be a promising therapeutic agent for glioma by suppressing RhoA/ROCK1 signaling. These findings pave the way for future research endeavors aimed at the development and optimization of scoparone‐based therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
ORCID-Profile: Jianning Zhang
Zitieren
APA
Zhou, Y., Han, Z., Zhao, Z., & Zhang, J. (2024). Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing RhoA / ROCK1 signaling. Environmental Toxicology. https://doi.org/10.1002/tox.23882
Vancouver
Zhou Y, Han Z, Zhao Z, Zhang J. Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing RhoA / ROCK1 signaling. Environmental Toxicology. 2024. doi:10.1002/tox.23882
BibTeX
@article{Zhou2024,
author = {Zhou, Yuhao and Han, Zhenying and Zhao, Zilong and Zhang, Jianning},
title = {Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing RhoA / ROCK1 signaling},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.23882}
}
EUVIMED